The US Centers for Disease Control and Prevention is currently investigating five hospitalizations that occurred in people ...

The European Commission (EC) has authorised the marketing of Bavarian Nordic's Vimkunya - the first chikungunya vaccine ...

Bhopal: Health authorities in Bhopal have intensified their monitoring and preventive efforts following a roughly 10% rise in ...

Five people have been hospitalized with cardiac and neurological symptoms after getting the chikungunya vaccine.

This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya ...

Biological E partners with Bavarian Nordic to expand access to Chikungunya Vaccine in low- and middle-income countries.

Biological E. and Bavarian Nordic partner to expand access to Chikungunya vaccine in LMICs, boosting manufacturing and jobs.

CNN has reached out to the CDC for comment. Chikungunya virus is typically spread to people through the bite of an infected mosquito. Most adults don’t receive the vaccine; it is sometimes ...

Two years on, Bavarian Nordic’s $380 million vaccine M&A move appears to be paying off. | Valneva may have won the ...

Hyderabad: Biopharma player Biological E (BE) entered into a strategic partnership with Danish vaccine maker Bavarian Nordic ...

First chikungunya vaccine approved in Europe for persons as young as 12 years old. On track for launch in key European ...

If granted, IXCHIQ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and ...